Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103044482A reveals a novel organotin anticancer agent with superior liposolubility. Discover cost-effective manufacturing routes for high-purity pharmaceutical intermediates.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN112174897B reveals a novel catalytic route for azoxystrobin intermediates, offering higher purity, reduced costs, and scalable agrochemical manufacturing solutions.
Novel metal-free method for 3-selenoindoles using NFSI. High yield, scalable process for pharmaceutical intermediates manufacturing.
Patent CN108033919B details a novel Pd-catalyzed oxidative cleavage route using styrenes, offering cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN115611726A details a metal-free method for cyclic ketone ring-opening. Achieve high-purity carboxylic acids with significant cost reduction in fine chemical manufacturing.
Patent CN102432496A details an acidic recrystallization method for carbidopa, ensuring high purity and yield. Discover cost-effective manufacturing solutions.
Patent CN102731357B details a water-based synthesis for N,N'-dicyclohexylthiourea, offering >99% yield and eliminating toxic organic solvents for safer API manufacturing.
Patent CN119176776A reveals a novel Lewis acid-catalyzed route for beta-lactamase inhibitor intermediates, offering high selectivity and simplified purification for reliable supply chains.
Patent CN102826985B details a high-yield 3-step synthesis for pharmaceutical intermediates. Discover cost-effective scaling and purity advantages for your supply chain.
Patent CN111217756B reveals a safer, scalable route for dexmedetomidine hydrochloride, eliminating high-risk hydrogenation and complex protection steps for reliable supply.
Patent CN107915649B details a rhodium-catalyzed route to tetrahydronaphthalene derivatives, offering high selectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN102971285A details a novel catalytic route for L-carnitine, eliminating toxic organotin reagents and enabling cost reduction in nutraceutical manufacturing.
Novel auxiliary agent for pretilachlor synthesis improves yield and fluidity. Reliable supply chain solution for agrochemical manufacturers seeking cost reduction.
Discover high-purity axial chiral 4-aryl alpha-carboline intermediates synthesized via novel NHC organocatalysis. Reliable supply chain solutions for pharmaceutical manufacturing.
Patent CN101379046A reveals a novel convergent synthesis for taxanes like TPI287, offering improved yield and purity for reliable pharmaceutical intermediates supplier networks.
Patent CN110240543B details a continuous flow synthesis for Vitamin A intermediates, offering higher yields and simplified purification for reliable supply chains.
Discover the novel GCLE-based synthesis of Cefepime Hydrochloride avoiding halogenated solvents. High purity, scalable process for reliable API intermediate supply.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Novel method using phenylketene achieves 68-72% yield without racemization, offering significant cost reduction in pharmaceutical manufacturing for oncology APIs.